<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00732719</url>
  </required_header>
  <id_info>
    <org_study_id>CW-0500-04-U332</org_study_id>
    <nct_id>NCT00732719</nct_id>
  </id_info>
  <brief_title>Compression Device Safety Study on Edema</brief_title>
  <official_title>A Phase II Non-Comparative Study Evaluating the Effects of the Compression Test Device on Oedema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ConvaTec Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Bristol-Myers Squibb</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>ConvaTec Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the safety of the prototype Compression Device in subjects with Oedema
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2004</start_date>
  <completion_date type="Actual">December 2004</completion_date>
  <primary_completion_date type="Actual">November 2004</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The nature and incidence of adverse events</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Volume reduction</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Oedema reduction</measure>
  </primary_outcome>
  <number_of_arms>7</number_of_arms>
  <enrollment type="Actual">12</enrollment>
  <condition>Edema</condition>
  <arm_group>
    <arm_group_label>Profile A</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Device worn; no pressure given (placebo)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 30mm Hg, Gaiter at 40 mm Hg, mid-calf at 30 mm Hg and upper cuff at 20mm Hg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 20mm Hg, Gaiter at 30 mm Hg, mid-calf at 20 mm Hg and upper cuff at 10mm Hg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile D</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 10mm Hg, Gaiter at 20 mm Hg, mid-calf at 10 mm Hg and upper cuff at 0mm Hg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile E</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 30mm Hg, Gaiter at 40 mm Hg, mid-calf at 40 mm Hg and upper cuff at 40mm Hg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile F</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 20mm Hg, Gaiter at 30 mm Hg, mid-calf at 30 mm Hg and upper cuff at 30mm Hg</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Profile G</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Foot at 10mm Hg, Gaiter at 20 mm Hg, mid-calf at 20 mm Hg and upper cuff at 20mm Hg</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device (unnamed) worn-no pressure given (placebo) from inflatable cuffs</intervention_name>
    <arm_group_label>Profile A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile B</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile D</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile E</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile F</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Prototype device(unnamed)-A battery operated inflatable pneumatic cuffs</intervention_name>
    <arm_group_label>Profile G</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subjects aged between 18 and 80, willing and able to provide written informed consent,
             and able to wear the device and follow the requirements of the protocol

          -  Subjects who have an ankle to brachial pressure index (ABPI) of at least 0.8.

          -  Subjects who suffer from chronic oedema (i.e. CEAP classification of C3, C4 or C5 1.)

          -  Subjects who have Chronic Venous Insufficiency (CVI), which has been present for 6
             weeks or longer and who have refluxes &gt;0.5 sec in one or more major venous segments,
             superficial or deep or both (CEAP classification: C3-C5 1.; Ep,s; As,d; Pr).

        Exclusion Criteria:

          -  Subjects with a history of skin sensitivity to any of the components of the study
             product.

          -  Subjects who have previously been entered into the study before

          -  Subjects who have a history of Deep Vein Thrombosis (DVT) within the last 6 months

          -  Subjects who have an active leg ulcer (i.e. CEAP classification of C6 1).

          -  Subjects with active cardiac disease or significant history of cardiac disease
             (including history of myocardial infarction, heart failure, valvular disease,
             arrhythmia and those with a pacemaker or have previously had a pacemaker).

          -  Subjects who have initiated treatment or changed the dose within the past month of
             pharmaceutical agents that reduce clotting e.g. aspirin (except low-dose aspirin),
             anti-platelets, anti-coagulants and coumarin.

          -  Subjects who are currently taking pharmaceutical agents that can modify the amount of
             leg oedema (e.g., diuretics, dihydropyridine calcium channel blockers, phlebotonic
             drugs, or fluctuating doses of systemic steroids) or have taken these agents within
             the last 10 days.

          -  Subjects who are pregnant

          -  Subjects who have worn compression therapy in the last 48 hours
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Wolfgang Vanscheidt</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hautarzt Phlebologe Allergologe</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hautarzt Phlebologe Allergologe</name>
      <address>
        <city>Freiburg</city>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>August 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 23, 2008</study_first_submitted>
  <study_first_submitted_qc>August 11, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2008</study_first_posted>
  <last_update_submitted>October 29, 2008</last_update_submitted>
  <last_update_submitted_qc>October 29, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 31, 2008</last_update_posted>
  <responsible_party>
    <name_title>Professor Wolfgang Vanscheidt</name_title>
    <organization>Hautarzt Phlebologe Allergologe</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

